hdr isap 2019

Annual meeting 2014

The annual meeting and post-ICAAC symposium took place on September 9th, 2014, 2:00-6:00 pm, Hemsley Fraser, Suite 900, 1615 M Street, NW, 20036 Washington DC, MD
ISAP symposium-kl

12:00 - 1:00 pm
1:00 - 1:45 pm
ISAP Council Meeting
ISAP General Meeting

2:00 – 2:10 pm

2:10 – 3:10 pm

Scientific presentation and discussion

PK/PD in the regulatory environment
Joga Gobburu, University of Maryland, School of Pharmacy, former head of pharmacometrics at FDA

3:10 - 3:40 pm

Break / informal discussion

3:40 – 5:40 pm

Scientific presentations by junior investigators

5:40- 6:00 pm

Discussion and closing remarks

Scientific presentations by junior investigators

 MW. Sadiq  A whole-body physiologically based pharmacokinetic model of ciprofloxacin for prediction of bacterial killing at the site of infection
 S. Aitken  Cefepime free minimum concentration to minimum inhibitory concentration ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia
 T-P. Lim  Multiple combination bactericidal testing-guided therapy is effective in the treatment of extensively drug-resistant Gram-negative bacteria infections
 E. Bassères  Antibiotic activity against different Pseudomonas aeruginosa phenotypes in an artificial sputum medium biofilm model
 A. Sultan  Bayesian estimation of levofloxacin pharmacokinetics in patients with tuberculosis

Online presentations (will be posted after ICAAC):
A. Deitchman The synergism between tigecycline and tetracycline: A protein binding-based approach
S. Wicha Pharmacodynamics of vancomycin or linezolid combined with meropenem against Staphylococcus aureus assessed by descriptive and semi-mechanistic modelling techniques

Download program